NC
Nant Capital, LLC disclosed a 19.9% stake in PDSB
Nant Capital, LLC reported owning 19.9% of PDS Biotechnology Corp (PDSB) (20,336,335 shares) in a Schedule 13D filed Sep 22, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13D